To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Critical Care ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The definition of preeclampsia.Br J Obstet Gynaecol. 1994; 101: 587-591
- The maternal syndrome of preeclampsia: a forme fruste of the systematic inflammatory response syndrome.Sepsis. 2000; 4: 43-47
- Preeclampsia: an excessive maternal inflammatory response to pregnancy.Am J Obstet Gynecol. 1999; 180: 499-506
- Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia.Am J Obstet Gynecol. 2000; 183: 140-147
- Platelet and coagulation abnormalities.in: Lindheimer M.D. Roberts J.M. Cunningham F.G. Chesley's hypertensive disorders in pregnancy. 2nd edition. Appleton and Lange, Stamford (NY)1999: 349-373
- Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome.Acta Obstetricia et Gynecologica Scandinavia. 2002; 81: 1095-1100
- The laboratory evaluation of hypertensive gravidas.Obstet Gynecol Surv. 1995; 50: 138-144
- Pregnancy-related mortality from preeclampsia and eclampsia.Obstet Gynecol. 2001; 97: 533-538
- Liver disease in toxemia of pregnancy.Am J Gastroenterol. 1986; 81: 1138-1144
- Aggressive versus expectant management of severe preeclampsia at 28-32 weeks gestation: a randomized controlled trial.Am J Obstet Gynecol. 1994; 171: 818-822
- Analysis of 454 pregnancies with severe preeclampsia/eclampsia HELLP syndrome using the 3-class system of classification.Am J Obstet Gynecol. 1993; 68: 386-391
- Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.Thromb Haemost. 1998; 79: 500-508
- Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann.Am J Reprod Immunol. 1997; 37: 427-434
- A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women.N Engl J Med. 1999; 340: 1723-1731
- Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery.Obstet Gynecol. 1990; 76: 737-741
- Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome).Am J Obstet Gynecol. 1993; 169: 1000-1006
- Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.Am J Obstet Gynecol. 1999; 181: 924-928
- Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis.Am J Obstet Gynecol. 1995; 172: 125-129
- Mortality and morbidity associated with early-onset preeclampsia.Hypertens Pregnancy. 2000; 19: 221-231
- Thrombosis in pregnancy: maternal and fetal issues.Lancet. 1999; 353: 1258-1265
- Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity.Crit Care Med. 2002; 30: 1883-1892
- Hepatic infarction associated with eclampsia.Am J Gastroenterol. 1990; 85: 588-592
- The natural history of HELLP syndrome: patterns of disease progression and regression.Am J Obstet Gynecol. 1991; 164: 1500-1513
- Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity.Am J Obstet Gynecol. 1999; 180: 1407-1414
- Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death.Am J Perinatol. 1995; 12: 310-313
- Care of the pregnancy complicated by HELLP syndrome.Gastroenterol Clin North Am. 1992; 21: 937-950
- The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.Prenat Diagn. 1997; 17: 601-606
- Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP).Am J Obstet Gynecol. 1994; 171: 1148-1153
- Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets.Am J Obstet Gynecol. 1994; 171: 1154-1158
- Plasma exchange for preeclampsia: I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome.Am J Obstet Gynecol. 1990; 162: 126-137
- Acute fatty liver of pregnancy.N Engl J Med. 1985; 313: 367-370
- Maternal and perinatal outcome in severe pregnancy-related liver disease.Hepatology. 1997; 26: 1258-1262
- Idiopathic fatty liver of pregnancy: findings in ten cases.Medicine (Baltimore). 1984; 63: 1-11
- A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.N Engl J Med. 1999; 340: 1723-1731
- Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.Am J Gastroenterol. 1996; 91: 2293-2300
- Acute fatty liver of pregnancy.Gut. 1968; 9: 489-493
- Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases.Am J Obstet Gynecol. 1994; 171: 1342-1347
- Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation.Hepatology. 1990; 11: 59-64
- Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia.Br J Obstet Gynaecol. 1995; 102: 20-25
- Activated protein C resistance (FV: Q506) and pregnancy.Thromb Haemost. 1999; 81: 532-537
- Antithrombin therapy for severe preeclampsia.Thromb Haemost. 2000; 84: 576-582
- Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med. 2001; 344: 699-709
Article info
Identification
Copyright
© 2004 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
